1 active not recruiting, 1 completed, 1 terminated. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Active not recruiting 1, Completed 1, Terminated 1 |
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow SMOFlipid: new trials by email Literature Review of SMOFlipid trials Research Report on SMOFlipid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| First-in-Human Safety and Tolerability Study of OPF-110 in Healthy Adults OPF-110, SMOFLIPID - Healthy Volunteers | Phase 1 | Active not recruiting | Otsuka Pharmaceutical Factory, Inc. | 24 | 2026-08-12 | 2026-10-19 |
| LIPIDS-P Trial Phase I/II Trial Smoflipid - Sepsis, Severe, Septic Shock | Phase 1 / Phase 2 | Completed | University of Florida | 59 | 2018-08-17 | 2025-08-11 |
| SMOFlipid to Lessen the Severity of Neonatal Cholestasis SMOFlipid - Cholestasis, Jaundice, Obstructive | Phase 1 / Phase 2 | Terminated | University of Florida | 2 | 2016-05-01 | 2017-04-17 |
Hyperphagia (2) · Cholestasis (1) · Enterocolitis, Necrotizing (1) · Jaundice, Obstructive (1) · Sepsis (1) · Shock, Septic (1)
University of Florida (2) · Otsuka Pharmaceutical Factory, Inc. (1)
United States (3)
Faheem W Guirgis, MD (1) · Josef Neu, MD (1)